» Articles » PMID: 26660529

AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users

Overview
Specialty Pharmacology
Date 2015 Dec 15
PMID 26660529
Citations 151
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A trade-off exists between building confidence in health-economic (HE) decision models and the use of scarce resources. We aimed to create a practical tool providing model users with a structured view into the validation status of HE decision models, to address this trade-off.

Methods: A Delphi panel was organized, and was completed by a workshop during an international conference. The proposed tool was constructed iteratively based on comments from, and the discussion amongst, panellists. During the Delphi process, comments were solicited on the importance and feasibility of possible validation techniques for modellers, their relevance for decision makers, and the overall structure and formulation in the tool.

Results: The panel consisted of 47 experts in HE modelling and HE decision making from various professional and international backgrounds. In addition, 50 discussants actively engaged in the discussion at the conference workshop and returned 19 questionnaires with additional comments. The final version consists of 13 items covering all relevant aspects of HE decision models: the conceptual model, the input data, the implemented software program, and the model outcomes.

Conclusions: Assessment of the Validation Status of Health-Economic decision models (AdViSHE) is a validation-assessment tool in which model developers report in a systematic way both on validation efforts performed and on their outcomes. Subsequently, model users can establish whether confidence in the model is justified or whether additional validation efforts should be undertaken. In this way, AdViSHE enhances transparency of the validation status of HE models and supports efficient model validation.

Citing Articles

Long-term cost-effectiveness of health behaviour intervention to manage type 2 diabetes in Nepal.

Dahal P, Vandelanotte C, Rawal L, Mahumud R, Paudel G, Lloyd M BMC Med. 2025; 23(1):153.

PMID: 40069657 PMC: 11900644. DOI: 10.1186/s12916-025-03981-8.


Current and Future Cost Burden of Myocardial Infarction in Australia: Dynamic Multistate Markov Model.

Abebe T, Ilomaki J, Livori A, Bell J, Morton J, Ademi Z J Gen Intern Med. 2025; .

PMID: 40038226 DOI: 10.1007/s11606-025-09423-8.


Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung Cancer.

Otten L, Buma A, Piet B, Ter Heine R, van den Heuvel M, Retel V Pharmacoecon Open. 2025; .

PMID: 39875696 DOI: 10.1007/s41669-025-00557-3.


Health economics assessment of statin therapy initiation thresholds for atherosclerosis prevention in China: a cost-effectiveness analysis.

Feng T, Zhang X, Xu J, Gao S, Yu X Int J Equity Health. 2025; 24(1):31.

PMID: 39856721 PMC: 11762857. DOI: 10.1186/s12939-025-02391-9.


Cost-utility analysis of MR imaging-guided transurethral ultrasound ablation for the treatment of low- to intermediate-risk localised prostate cancer.

Muhler P, Akuamoa-Boateng D, Rosenbrock J, Stock S, Muller D, Heidenreich A BMJ Open. 2025; 15(1):e088495.

PMID: 39800402 PMC: 11752021. DOI: 10.1136/bmjopen-2024-088495.


References
1.
Philips Z, Bojke L, Sculpher M, Claxton K, Golder S . Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics. 2006; 24(4):355-71. DOI: 10.2165/00019053-200624040-00006. View

2.
Evers S, Goossens M, de Vet H, van Tulder M, Ament A . Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int J Technol Assess Health Care. 2005; 21(2):240-5. View

3.
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D . Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Pharmacoeconomics. 2013; 31(5):361-7. DOI: 10.1007/s40273-013-0032-y. View

4.
Kleijnen J . Ethical issues in engineering models: an operations researcher's reflections. Sci Eng Ethics. 2010; 17(3):539-52. PMC: 3183247. DOI: 10.1007/s11948-010-9215-5. View

5.
Chilcott J, Tappenden P, Rawdin A, Johnson M, Kaltenthaler E, Paisley S . Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Health Technol Assess. 2010; 14(25):iii-iv, ix-xii, 1-107. DOI: 10.3310/hta14250. View